Cellectar Biosciences is a small-cap biotech stock to keep on your radar due to promising clinical data and potential FDA approval.
Source Post
The creator highlights Cellectar Biosciences (CLRB) as a small-cap biotech stock to watch, citing positive...
Oct 14, 2026
The creator highlights Cellectar Biosciences (CLRB) as a small-cap biotech stock to watch, citing positive clinical trial results for its lead treatment, iopofosine I, and upcoming FDA milestones.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.